Pinilla; Clemencia

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pinilla; Clemencia.The latest application filed is for "selective small molecule peptidomimetic melanocortin ligands".

Company Profile

1.12.23

Pinilla; Clemencia - Port St. Lucie FL
Pinilla; Clemencia - Cardiff CA
Pinilla; Clemencia - Cardif CA
Pinilla; Clemencia - San Diego CA
Pinilla; Clemencia - Cardiff by the Sea CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Selective Small Molecule Peptidomimetic Melanocortin Ligands App 20220213068 - Haskell-Luevano; Carrie ; et al.	2022-07-07
Melanocortin ligands and methods of use thereof Grant 10,899,793 - Haskell-Luevano , et al. January 26, 2	2021-01-26
High-affinity small molecule formylpeptide receptor ligands from screening of combinatorial mixture-based libraries Grant 10,048,272 - Edwards , et al. August 14, 2	2018-08-14
Melanocortin Ligands And Methods Of Use Thereof App 20170342107 - Haskell-Luevano; Carrie ; et al.	2017-11-30
High-affinity Small Molecule Formylpeptide Receptor Ligands From Screening Of Combinatorial Mixture-based Libraries App 20160320402 - Edwards; Bruce S. ; et al.	2016-11-03
High-affinity small molecule formylpeptide receptor ligands from screening of combinatorial mixture-based libraries Grant 9,310,364 - Edwards , et al. April 12, 2	2016-04-12
Cancer Vaccines And Vaccination Methods App 20120156232 - Yu; John S. ; et al.	2012-06-21
Conjugates of membrane translocating agents and pharmaceutically active agents Grant 8,017,727 - O'Mahony , et al. September 13, 2	2011-09-13
Methods And Compositions For Derepression Of Iap-inhibited Caspase App 20110183358 - Reed; John C. ; et al.	2011-07-28
Conjugates Of Membrane Translocating Agents And Pharmaceutically Active Agents App 20100168381 - O'Mahony; Daniel ; et al.	2010-07-01
Conjugates of membrane translocating agents and pharmaceutically active agents Grant 7,638,599 - O'Mahony , et al. December 29, 2	2009-12-29
Peptide mixtures with immunomodulatory activity App 20090214580 - Houghten; Richard A. ; et al.	2009-08-27
Methods and compositions for derepression of IAP-inhibited caspase App 20090043099 - Reed; John C. ; et al.	2009-02-12
Cancer Vaccines And Vaccination Methods App 20080311142 - Yu; John S. ; et al.	2008-12-18
Methods and compositions for derepression of IAP-inhibited caspase Grant 7,217,688 - Reed , et al. May 15, 2	2007-05-15
Isolated, ssx-2 and ssx-2 related peptides useful as hla binders and ctl epitopes, and uses thereof App 20070105779 - Valmori; Danila ; et al.	2007-05-10
Pharmaceutical formulations and ligands for use therein; mimetics for UEA-1 Grant 7,166,296 - Houghten , et al. January 23, 2	2007-01-23
Methods and compositions for derepression of IAP-inhibited caspase App 20070003535 - Reed; John C. ; et al.	2007-01-04
Pharmaceutical Formulations and Ligands for Use Therein; Mimetics for UEA-1 App 20060276628 - Houghten; Richard ; et al.	2006-12-07
Methods and composition for derepressions of IAP-inhibited caspase App 20060258581 - Reed; John C. ; et al.	2006-11-16
Methods and compositions for derepression of IAP-inhibited caspase App 20060211627 - Reed; John C. ; et al.	2006-09-21
Conjugates of membrane translocating agents and pharmaceutically active agents App 20060100149 - O'Mahony; Daniel ; et al.	2006-05-11
Methods and compositions for derepression of IAP-inhibited caspase App 20050159359 - Reed, John C. ; et al.	2005-07-21
Methods and compositions for derepression of IAP-inhibited caspase Grant 6,911,426 - Reed , et al. June 28, 2	2005-06-28
Methods and compositions for derepression of IAP-inhibited caspase App 20050119176 - Reed, John C. ; et al.	2005-06-02
Conjugates of membrane translocating agents and pharmaceutically active agents App 20050101762 - O'Mahony, Daniel ; et al.	2005-05-12
System and method for identifying t cell and other epitopes and the like App 20040072246 - Martin, Roland ; et al.	2004-04-15
Pharmaceutical formulations and ligands for use therein; mimetics for UEA-1 App 20040062796 - Houghten, Richard ; et al.	2004-04-01
Recombination modulators and methods for producing and using the same App 20040002441 - Segall, Anca ; et al.	2004-01-01
Conjugates of membrane translocating agents and pharmaceutically active agents App 20030181367 - O'Mahony, Daniel ; et al.	2003-09-25
Methods and compositions for derepression of IAP-inhibited caspase App 20030180805 - Reed, John C. ; et al.	2003-09-25
Dialkyl ureas as calcitonin mimetics Grant 6,391,917 - Petrie , et al. May 21, 2	2002-05-21
Dimeric oligopeptide mixture sets Grant 6,287,787 - Houghten , et al. September 11, 2	2001-09-11
Scanning synthetic peptide combinatorial libraries: oligopeptide mixture sets having a one predetermined residue at a single, predetermined position, methods of making and using the same Grant 5,556,762 - Pinilla , et al. September 17, 1	1996-09-17
Equimolar multiple oligomer mixtures, especially oligopeptide mixtures Grant 5,504,190 - Houghten , et al. April 2, 1	1996-04-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.